ArticleJournal of thoracic disease2025
Outcomes of minimally invasive lung resection with concomitant chest wall resection in non-small cell lung cancer (NSCLC).
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Traditionally, lung and chest wall (CW) resections were performed via an open approach for non-small cell lung cancer (NSCLC) with CW involvement. Our objective is to examine the outcomes of patients with NSCLC and CW involvement resected through a minimally invasive (MIS) [video-assisted thoracoscopic surgery (VATS) or robotic] approach. Methods: This is a retrospective cohort study of the 2021 National Cancer Database (NCDB). We examined patients >18 years who underwent MIS or open lung and CW resection for clinically N0M0 NSCLC between 2010 and 2020. Outcomes studied include 30-, 90-day mortality, and readmission. Additionally, the number of nodes examined, margins, and rate of nodal upstaging were analyzed. Results: A total of 1,370 patients treated with an open resection and 352 patients treated with a MIS approach were examined. The average age at diagnosis was 66 years. The average primary tumor size was 4.75 cm (3.2-6.5 cm) in the MIS cohort and 5.7 cm (4.2-7.3 cm) in the open cohort. There was a significant difference in 30-day mortality between cohorts (P=0.002). There were no significant differences in other outcome measures (90-day mortality, readmission). There was no significant difference in margin positivity or nodal upstaging. There were more overall nodes examined in the MIS cohort (14 Conclusions: This study suggests that MIS lung and CW resection is associated with similar short and long-term outcomes in most measures as compared to open surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.